Metabolomic investigations in cerebrospinal fluid of Parkinson's disease.

Metabolomic investigations in cerebrospinal fluid of Parkinson's disease.

The underlying mechanisms of Parkinson´s disease are not completely revealed. Especially, early diagnostic biomarkers are lacking. To characterize early pathophysiological events, research is focusing on metabolomics. In this case-control study we investigated the metabolic profile of 31 Parkinson´s...

Full description

Bibliographic Details
Main Authors:	Desiree Willkommen, Marianna Lucio, Franco Moritz, Sara Forcisi, Basem Kanawati, Kirill S Smirnov, Michael Schroeter, Ali Sigaroudi, Philippe Schmitt-Kopplin, Bernhard Michalke
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2018-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0208752

Similar Items

Integrative Metabolomic and Metallomic Analysis in a Case–Control Cohort With Parkinson’s Disease
by: Marianna Lucio, et al.
Published: (2019-12-01)

Elemental fingerprint: Reassessment of a cerebrospinal fluid biomarker for Parkinson's disease
by: Fabian Maass, et al.
Published: (2020-02-01)

Changes in Brain Metallome/Metabolome Pattern due to a Single i.v. Injection of Manganese in Rats.
by: Katharina Neth, et al.
Published: (2015-01-01)

Pathway analysis of the transcriptome and metabolome of salt sensitive and tolerant poplar species reveals evolutionary adaption of stress tolerance mechanisms
by: Schmitt-Kopplin Philippe, et al.
Published: (2010-07-01)

Iron Redox Speciation Analysis Using Capillary Electrophoresis Coupled to Inductively Coupled Plasma Mass Spectrometry (CE-ICP-MS)
by: Bernhard Michalke, et al.
Published: (2019-03-01)

Usage of FT-ICR-MS Metabolomics for Characterizing the Chemical Signatures of Barrel-Aged Whisky
by: Chloé Roullier-Gall, et al.
Published: (2018-02-01)

Relationships between drought, heat and air humidity responses revealed by transcriptome-metabolome co-analysis
by: Elisabeth Georgii, et al.
Published: (2017-07-01)

The Metabolomic Approach Reveals the Alteration in Human Serum and Cerebrospinal Fluid Composition in Parkinson’s Disease Patients
by: Szymon Plewa, et al.
Published: (2021-09-01)

The role of fecal sulfur metabolome in inflammatory bowel diseases
by: Alesia Walker, et al.
Published: (2021-07-01)

Metabolomics reveals metabolic biomarkers of Crohn's disease.
by: Janet Jansson, et al.
Published: (2009-01-01)

Time Course of Metabolomic Alterations in Cerebrospinal Fluid After Aneurysmal Subarachnoid Hemorrhage
by: Wing Mann Ho, et al.
Published: (2020-06-01)

Disease-related changes in the cerebrospinal fluid metabolome in amyotrophic lateral sclerosis detected by GC/TOFMS.
by: Anna Wuolikainen, et al.
Published: (2011-04-01)

High precision mass measurements for wine metabolomics
by: Chloé eRoullier-Gall, et al.
Published: (2014-11-01)

High metabolomic microdiversity within co-occurring isolates of the extremely halophilic bacterium Salinibacter ruber.
by: Josefa Antón, et al.
Published: (2013-01-01)

Data processing for fennel protein characterization by Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR-MS)
by: Maria Teresa Melfi, et al.
Published: (2021-04-01)

Doping control using high and ultra-high resolution mass spectrometry based non-targeted metabolomics-a case study of salbutamol and budesonide abuse.
by: Agneta Kiss, et al.
Published: (2013-01-01)

Cerebrospinal fluid metabolomics identifies 19 brain-related phenotype associations
by: Daniel J. Panyard, et al.
Published: (2021-01-01)

MassTRIX reloaded: combined analysis and visualization of transcriptome and metabolome data.
by: Brigitte Wägele, et al.
Published: (2012-01-01)

Targeted metabolomic profiling of cerebrospinal fluid from patients with progressive multifocal leukoencephalopathy.
by: Yi Luo, et al.
Published: (2020-01-01)

NMR metabolomics of cerebrospinal fluid differentiates inflammatory diseases of the central nervous system.
by: Caitlin D French, et al.
Published: (2018-12-01)

Metabolomics of Cerebrospinal Fluid from Healthy Subjects Reveal Metabolites Associated with Ageing
by: Henrik Carlsson, et al.
Published: (2021-02-01)

Metabolite Profiles of the Cerebrospinal Fluid in Neurosyphilis Patients Determined by Untargeted Metabolomics Analysis
by: Li-Li Liu, et al.
Published: (2019-02-01)

Cerebrospinal fluid metabolomics: detection of neuroinflammation in human central nervous system disease
by: Jingya Yan, et al.
Published: (2021-01-01)

An Alzheimer-type cerebrospinal fluid profile in early Parkinson's disease
by: Chamoun, Mario-Christofer
Published: (2019)

Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease
by: Jens B. Schröder, et al.
Published: (2018-12-01)

Data Processing Optimization in Untargeted Metabolomics of Urine Using Voigt Lineshape Model Non-Linear Regression Analysis
by: Kristina E. Haslauer, et al.
Published: (2021-04-01)

Profiling Inflammatory Extracellular Vesicles in Plasma and Cerebrospinal Fluid: An Optimized Diagnostic Model for Parkinson’s Disease
by: Elena Vacchi, et al.
Published: (2021-02-01)

LC-HRMS data as a result of untargeted metabolomic profiling of human cerebrospinal fluid
by: Florence Mehl, et al.
Published: (2018-12-01)

Assessment of the Central Effects of Natural Uranium via Behavioural Performances and the Cerebrospinal Fluid Metabolome
by: P. Lestaevel, et al.
Published: (2016-01-01)

Small Molecules Present in the Cerebrospinal Fluid Metabolome Influence Superoxide Dismutase 1 Aggregation
by: Isabel Cardoso, et al.
Published: (2013-09-01)

LC-MS/MS based targeted metabolomics method for analysis of serum and cerebrospinal fluid
by: Szymon Plewa, et al.
Published: (2019-02-01)

Increased Noradrenaline as an Additional Cerebrospinal Fluid Biomarker in PSP-Like Parkinsonism
by: Rocco Cerroni, et al.
Published: (2020-06-01)

Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson’s disease
by: Pisani Valerio, et al.
Published: (2012-08-01)

Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson's disease
by: Karayel, O., et al.
Published: (2022)

Predictive ability of cerebrospinal fluid biomarkers in diagnosing and evaluating Parkinson's disease
by: Wang, Michelle J
Published: (2014)

A Comparative Study on Neurochemistry of Cerebrospinal Fluid in Advanced Parkinson's Disease
by: H. Liu, et al.
Published: (1999-02-01)

Impact of Glutathione on Wines Oxidative Stability: A Combined Sensory and Metabolomic Study
by: Maria Nikolantonaki, et al.
Published: (2018-06-01)

Cerebrospinal Fluid Levels of Chromogranin A in Parkinson’s Disease and Multiple System Atrophy
by: Michaela Kaiserova, et al.
Published: (2021-01-01)

Parkinson’s Disease With Depression: The Correlations Between Neuroinflammatory Factors and Neurotransmitters in Cerebrospinal Fluid
by: Teng-hong Lian, et al.
Published: (2020-10-01)

Correlated levels of cerebrospinal fluid pathogenic proteins in drug-naïve Parkinson’s disease
by: Hidetomo Murakami, et al.
Published: (2019-06-01)